Transcode Therapeutics (RNAZ) Invested Capital (2020 - 2021)
Transcode Therapeutics' (RNAZ) quarterly Invested Capital came in at $35685.0 in Q4 2021, down 98.41% YoY from $2.2 million in Q4 2020, and little changed on a QoQ basis from $35525.0 in Q2 2021.
Transcode Therapeutics (RNAZ) Invested Capital (2020 - 2021) Analysis & Trends
Transcode Therapeutics (RNAZ) has 2 years of Invested Capital data on file, last reported at $35685.0 in Q4 2021.
- Quarterly Invested Capital fell 98.41% year-over-year to $35685.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $35685.0 (down 98.43% YoY) and the FY2021 annual result came in at $35685.0, down 98.41% from the prior year.
- Invested Capital held at $35685.0 in Q4 2021, from $35525.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $2.2 million in Q4 2020 to a low of $35525.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Transcode Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 35,685.00 |
| Jun 30, 2021 | 35,525.00 |
| Dec 31, 2020 | 2.24 Mn |